Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
second_navbar.gif (585 bytes)
Past Issue

Vol. 7, No. 6
Nov–Dec 2001

Download Article
PDF
Help
Feedback


 
Modeling Potential Responses to Smallpox as a Bioterrorist Weapon

Appendix II: Modeling Potential Responses to Smallpox as a Bioterrorist Weapon: Additional Results from Sensitivity Analyses


 

Table 1. Sensitivity analyses: Effect on number of cases of smallpox as a result of variations in numbers initially infected, numbers infected per infectious person, intervention start days, and quarantine and vaccination effectiveness.


No. initially infecteda No. infected per infectious personb Start dayc Quarantine: % removal per dayd Vaccination: % reduction in transmissione Cumulative total cases at 365 days Daily cases at 365 days Increase or decrease 
(+/–f )

100 2 30 10 Nilg 1.5 million 32,548 +
100 2 30 25 Nil 2,455 2
100 2 30 10 25 10,512 51 +
100 2 45 10 33 6,063 8
100 2 45 25 33 1,548 0
100 2 45 25 Nil 4,879 4
100 5 30 25 33 54.5 million 1.6 million +
100 5 30 25 66 4,116 0
100 5 30 50 Nil 9.4 million 220,562 +
100 5 30 70 Nil 24,437 75 +
100 5 30 80 Nil 6,282 1
100 5 45 25 66 19,821 1
1,000 2 30 10 Nil 14.8 million 325,480 +
1,000 2 30 10 25 105,117 511 +
1,000 2 30 10 33 30,872 37
1,000 2 30 25 33 7,370 0
1,000 2 45 25 Nil 48,975 37
1,000 2 45 10 33 60,392 78
1,000 2 45 25 33 15,471 0

aNumber initially infected refers to those who are exposed during a release such that they become infectious. This excludes those who are exposed but either do not become ill or do not become infectious.
b
The number of persons infected per infectious person is the transmission rate.
c
Start day, for both quarantine and vaccination interventions, refers to the day postrelease, with the day of release being day 1.
d
Quarantine refers to removal of infectious persons only, starting on the first day of overt symptoms (i.e., rash). At a 25% daily removal rate, a cohort of all those entering the first day of overt symptoms is entirely removed in 17 days (18 to 20 days postincubation) after day 1 of overt symptoms, with 90% removed in 9 days. At a 10% daily removal, a cohort of all those entering the first day of overt symptoms is entirely removed in 44 days (45 to 47 days post incubation) after day 1 of overt symptoms, with 90% removed in 22 days. At a daily removal rate of 80%, a cohort of all those entering their first day of overt symptoms is entirely removed in 3 days (4 to 6 days postincubation) after day 1 of overt symptoms, with 90% removed in 2 days.
e
Vaccination is assumed to reduce the transmission rate by a given percentage (e.g., 25% reduction results in transmission declining from 2.0 to 1.5 persons infected per infectious person, and 33% reduces transmission from 2.0 to 1.32).
f
(+) = an increasing rate of daily cases on day 365, and thus the modeled interventions will not stop the transmission of smallpox.  (–) = a decreasing rate of daily cases, such that the interventions modeled will eventually stop the transmission of smallpox.
g
Nil = vaccine not used in this scenario.

  

 

Table 2. Sensitivity analyses: minimum levels of intervention needed to stop transmission of smallpox by days 75, 150, and 225 postrelease


Target stop daya Start day of interventionsa No. infected per infectious personb Quarantine: Minimum % removal per dayc Vaccination: Minimum % reduction in transmission (transmission rate)d

75 30 3 99.4 Nile (3.00)
75 30 3 Nilf 90.5 (0.29)
75 30 3 25 76.7 (0.70)
75 30 3 50 56.2 (1.32)
75 30 3 82.5 25.0 (2.25)
75 30 2 25 58.0 (0.84)
75 30 5 50 78.9 (1.06)
75 45 2 50 58.5 (0.83)
75 45 3 50 81.2 (0.57)
150 30 3 63.5 Nile (3.00)
150 30 3 Nilf 80.0 (0.60)
150 30 3 25 53.7 (1.39)
150 30 3 50 19.7 (2.41)
150 30 3 46.2 25.0 (2.25)
150 30 2 25 25.8 (1.49)
150 30 5 50 55.7 (2.22)
150 45 2 50 Nile (2.00)
150 45 3 50 33.3 (2.00)
225 30 3 53.8 Nile (3.00)
225 30 3 Nilf 75.8 (0.73)
225 30 3 25 45.2 (1.65)
225 30 3 50 6.0 (2.82)
225 30 3 38.1 25.0 (2.25)
225 30 2 25 14.3 (1.72)
225 30 5 50 46.5 (2.68)
225 45 2 50 Nile (2.00)
225 45 3 50 14.8 (2.56)

aTarget stop day and start day of interventions refer to days postrelease, with day of release being day 1.
b
The number of persons infected per infectious person is the transmission rate.
c
Quarantine refers to removal of infectious persons only, starting on the first day of overt symptoms (i.e., rash). Rates are the minimum rates needed, when combined with vaccination, to ensure that there is zero transmission by the target date. With 25% daily removal rate of infectious persons, a cohort of all those entering the first day of overt symptoms is entirely removed in 17 days (18 to 20 days postincubation) after day 1 of overt symptoms, with 90% removed in 9 days after entering overtly symptomatic period. With 50% daily removal of infectious persons, a cohort of all those entering their first day of overt symptoms is entirely removed in 7 days (8 to 10 days postincubation) after day 1 of overt symptoms, with 90% removed in 4 days after entering overtly symptomatic period.
d
Vaccination assumed to reduce the transmission rate by a given percentage (e.g., 25% reduction results in transmission decreasing from 3.0 to 2.25 persons infected per infectious person). Percentages are the minimum percentage reduction in the assumed rate of transmission needed, when combined with quarantine, to ensure zero transmission by the target date. The resultant transmission rate, after reduction, is in parentheses.
e
For these scenarios, the assumed quarantine rate is such that the target dates can be attained without the use of vaccination.
f
For these scenarios, the assumed vaccination-induced reduction in transmission is such that the target dates can be attained without the use of quarantine.

  


Comments to the EID Editors
Please use this form to submit comments to the EID Editors.

Email (optional)


Home | Top of Page | Current Issue | Expedited | Upcoming Issue | Past Issue | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | Search | Health Topics A-Z

This page last reviewed December 20, 2001

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention